LRMR
Price
$3.20
Change
+$0.09 (+2.89%)
Updated
Jul 3 closing price
Capitalization
204.89M
32 days until earnings call
TNFA
Price
$0.12
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
1.68M
Interact to see
Advertisement

LRMR vs TNFA

Header iconLRMR vs TNFA Comparison
Open Charts LRMR vs TNFABanner chart's image
Larimar Therapeutics
Price$3.20
Change+$0.09 (+2.89%)
Volume$516.01K
Capitalization204.89M
TNF Pharmaceuticals
Price$0.12
Change-$0.00 (-0.00%)
Volume$3.41M
Capitalization1.68M
LRMR vs TNFA Comparison Chart in %
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. TNFA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a StrongBuy and TNFA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (LRMR: $3.20 vs. TNFA: $0.12)
Brand notoriety: LRMR and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 40% vs. TNFA: 65%
Market capitalization -- LRMR: $204.89M vs. TNFA: $1.68M
LRMR [@Biotechnology] is valued at $204.89M. TNFA’s [@Biotechnology] market capitalization is $1.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than TNFA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 6 TA indicator(s) are bullish while TNFA’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 6 bullish, 4 bearish.
  • TNFA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than TNFA.

Price Growth

LRMR (@Biotechnology) experienced а +3.90% price change this week, while TNFA (@Biotechnology) price change was -5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

LRMR is expected to report earnings on Nov 18, 2025.

TNFA is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($205M) has a higher market cap than TNFA($1.68M). LRMR YTD gains are higher at: -17.313 vs. TNFA (-89.722). TNFA has higher annual earnings (EBITDA): -8.35M vs. LRMR (-105.02M). LRMR has more cash in the bank: 158M vs. TNFA (5.88M). TNFA has less debt than LRMR: TNFA (2.68K) vs LRMR (4.87M). LRMR (0) and TNFA (0) have equivalent revenues.
LRMRTNFALRMR / TNFA
Capitalization205M1.68M12,224%
EBITDA-105.02M-8.35M1,258%
Gain YTD-17.313-89.72219%
P/E RatioN/AN/A-
Revenue00-
Total Cash158M5.88M2,688%
Total Debt4.87M2.68K181,703%
FUNDAMENTALS RATINGS
LRMR vs TNFA: Fundamental Ratings
LRMR
TNFA
OUTLOOK RATING
1..100
5090
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4397
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (8) in the null industry is in the same range as LRMR (22). This means that TNFA’s stock grew similarly to LRMR’s over the last 12 months.

TNFA's Profit vs Risk Rating (100) in the null industry is in the same range as LRMR (100). This means that TNFA’s stock grew similarly to LRMR’s over the last 12 months.

TNFA's SMR Rating (99) in the null industry is in the same range as LRMR (100). This means that TNFA’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (43) in the null industry is somewhat better than the same rating for TNFA (97). This means that LRMR’s stock grew somewhat faster than TNFA’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as TNFA (100). This means that LRMR’s stock grew similarly to TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRTNFA
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSSRF0.04N/A
N/A
Kesselrun Resources Ltd.
SVKEF18.65N/A
N/A
Skandinaviska Enskilda Banken AB
VLPNF21.93N/A
N/A
Voestalpine AG
WRDEF16.00N/A
N/A
Wereldhave NV
ACKRF0.08N/A
-0.48%
American Creek Resources, Ltd.

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+2.89%
ERAS - LRMR
54%
Loosely correlated
-0.69%
ATXS - LRMR
50%
Loosely correlated
+1.40%
SYRE - LRMR
49%
Loosely correlated
+1.68%
ALEC - LRMR
49%
Loosely correlated
+6.34%
ACLX - LRMR
48%
Loosely correlated
+1.24%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with COGT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
+2.07%
COGT - TNFA
39%
Loosely correlated
+4.99%
PHAT - TNFA
39%
Loosely correlated
+0.11%
TVGN - TNFA
36%
Loosely correlated
-0.80%
LRMR - TNFA
32%
Poorly correlated
+2.89%
BPMC - TNFA
29%
Poorly correlated
N/A
More